Aleksandr Shamanaev
A Model of Zymogen Factor XII: Insights into Protease Activation
Shamanaev, Aleksandr; Ma, Yujie; Ponczek, Michal B.; Sun, Mao-fu; Cheng, Qiufang; Dickeson, S. Kent; McCarty, Owen J.T.; Emsley, Jonas; Mohammed, Bassem M.; Gailani, David
Authors
Yujie Ma
Michal B. Ponczek
Mao-fu Sun
Qiufang Cheng
S. Kent Dickeson
Owen J.T. McCarty
Professor JONAS EMSLEY jonas.emsley@nottingham.ac.uk
PROFESSOR OF MACROMOLECULAR CRYSTALLOGRAPHY
Bassem M. Mohammed
David Gailani
Abstract
In plasma, the zymogens factor XII (FXII) and prekallikrein reciprocally convert each other to the proteases FXIIa and plasma kallikrein (PKa). PKa cleaves high-molecular-weight kininogen (HK) to release bradykinin, which contributes to regulation of blood vessel tone and permeability. Plasma FXII is normally in a “closed” conformation that limits activation by PKa. When FXII binds to a surface during contact activation it assumes an “open” conformation that increases the rate of activation by PKa. Mutations in FXII that disrupt the closed conformation have been identified in patients with conditions associated with excessive bradykinin formation. Using FXII structures from the AlphaFold data base, we generated models for the closed form of human FXII that we tested with site-directed mutagenesis. The models predict multiple interactions between the fibronectin type 2, kringle and catalytic domains involving highly conserved amino acids that restrict access to the FXII activation cleavage sites. Based on the model, we expressed FXII with single amino acid substitutions and studied their effects on FXII activation by PKa. Replacements for Arg36 in the fibronectin type 2 domain; Glu225, Asp253 or Trp268 in the kringle domain, or Lys346 near the activation cleavage site were activated >10-fold faster by PKa than wild type FXII. Adding these proteins to plasma resulted in rapid HK cleavage due to markedly enhanced reciprocal activation with PK. The results support a model that explains the behavior of FXII in solution. Conformational changes involving the identified amino acids likely occur when FXII binds to a surface to facilitate activation.
Citation
Shamanaev, A., Ma, Y., Ponczek, M. B., Sun, M.-F., Cheng, Q., Dickeson, S. K., McCarty, O. J., Emsley, J., Mohammed, B. M., & Gailani, D. (2025). A Model of Zymogen Factor XII: Insights into Protease Activation. Blood Advances, https://doi.org/10.1182/bloodadvances.2025015842
Journal Article Type | Article |
---|---|
Acceptance Date | Jan 16, 2025 |
Online Publication Date | Jan 30, 2025 |
Publication Date | Jan 30, 2025 |
Deposit Date | Feb 2, 2025 |
Publicly Available Date | Feb 4, 2025 |
Electronic ISSN | 2473-9529 |
Publisher | American Society of Hematology |
Peer Reviewed | Peer Reviewed |
DOI | https://doi.org/10.1182/bloodadvances.2025015842 |
Public URL | https://nottingham-repository.worktribe.com/output/44825829 |
Publisher URL | https://ashpublications.org/bloodadvances/article/doi/10.1182/bloodadvances.2025015842/535372/A-Model-of-Zymogen-Factor-XII-Insights-into |
Files
A Model of Zymogen Factor XII: Insights into Protease Activation
(7.3 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc-nd/4.0/
You might also like
Aptamer BT200 blocks interaction of K1405-1408 in the VWF-A1 domain with macrophage LRP1
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search